 | • レポートコード：MRC2-11QY12012 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃腸治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、非経口）市場規模、用途別（IBD、過敏性腸症候群（IBS））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃腸治療薬の競争状況、市場シェア ・世界の胃腸治療薬市場：種類別市場規模 2015年-2020年（経口、非経口） ・世界の胃腸治療薬市場：種類別市場規模予測 2021年-2026年（経口、非経口） ・世界の胃腸治療薬市場：用途別市場規模 2015年-2020年（IBD、過敏性腸症候群（IBS）） ・世界の胃腸治療薬市場：用途別市場規模予測 2021年-2026年（IBD、過敏性腸症候群（IBS）） ・北米の胃腸治療薬市場分析：米国、カナダ ・ヨーロッパの胃腸治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃腸治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃腸治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃腸治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Allergan、Johnson & Johnson、Takeda、Novartis、Pfizer、Merck、F. Hoffmann-La Roche、Eli Lilly、AstraZeneca、Procter & Gamble、Tillotts Pharma、Takeda、GlaxoSmithKline、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn’s disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The global Gastrointestinal Therapeutics market size is projected to reach US$ 35190 million by 2026, from US$ 33290 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Gastrointestinal Therapeutics Scope and Market Size
Gastrointestinal Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Market segment by Type, the product can be split into
Oral
Parenteral
Market segment by Application, split into
IBD
Irritable Bowel Syndrome (IBS)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 IBD
1.5.3 Irritable Bowel Syndrome (IBS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.5 Date of Enter into Gastrointestinal Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Gastrointestinal Therapeutics Introduction
13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Gastrointestinal Therapeutics Introduction
13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Gastrointestinal Therapeutics Introduction
13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Gastrointestinal Therapeutics Introduction
13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.7.5 Merck Recent Development
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Details
13.8.2 F. Hoffmann-La Roche Business Overview
13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.8.5 F. Hoffmann-La Roche Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview
13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.10.5 AstraZeneca Recent Development
13.11 Procter & Gamble
10.11.1 Procter & Gamble Company Details
10.11.2 Procter & Gamble Business Overview
10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.11.5 Procter & Gamble Recent Development
13.12 Tillotts Pharma
10.12.1 Tillotts Pharma Company Details
10.12.2 Tillotts Pharma Business Overview
10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.12.5 Tillotts Pharma Recent Development
13.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview
10.13.3 Takeda Gastrointestinal Therapeutics Introduction
10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.13.5 Takeda Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Gastrointestinal Therapeutics Introduction
10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.15.5 Amgen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gastrointestinal Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
Table 3. Ranking of Global Top Gastrointestinal Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Gastrointestinal Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Gastrointestinal Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Gastrointestinal Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Gastrointestinal Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Gastrointestinal Therapeutics Players
Table 18. Global Gastrointestinal Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Gastrointestinal Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019)
Table 21. Global Gastrointestinal Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 24. Date of Enter into Gastrointestinal Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Gastrointestinal Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Gastrointestinal Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 34. North America Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 36. North America Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 40. Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 46. China Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 48. China Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 52. Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 64. India Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 66. India Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Gastrointestinal Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Gastrointestinal Therapeutics Market Share (2019-2020)
Table 70. Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. Takeda Company Details
Table 90. Takeda Business Overview
Table 91. Takeda Product
Table 92. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 93. Takeda Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. F. Hoffmann-La Roche Business Overview
Table 110. F. Hoffmann-La Roche Product
Table 111. F. Hoffmann-La Roche Company Details
Table 112. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Product
Table 117. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 118. Eli Lilly Recent Development
Table 119. AstraZeneca Company Details
Table 120. AstraZeneca Business Overview
Table 121. AstraZeneca Product
Table 122. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Procter & Gamble Company Details
Table 125. Procter & Gamble Business Overview
Table 126. Procter & Gamble Product
Table 127. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 128. Procter & Gamble Recent Development
Table 129. Tillotts Pharma Company Details
Table 130. Tillotts Pharma Business Overview
Table 131. Tillotts Pharma Product
Table 132. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 133. Tillotts Pharma Recent Development
Table 134. Takeda Company Details
Table 135. Takeda Business Overview
Table 136. Takeda Product
Table 137. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 138. Takeda Recent Development
Table 139. GlaxoSmithKline Company Details
Table 140. GlaxoSmithKline Business Overview
Table 141. GlaxoSmithKline Product
Table 142. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 143. GlaxoSmithKline Recent Development
Table 144. Amgen Company Details
Table 145. Amgen Business Overview
Table 146. Amgen Product
Table 147. Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020) (Million US$)
Table 148. Amgen Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. IBD Case Studies
Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
Figure 7. Gastrointestinal Therapeutics Report Years Considered
Figure 8. Global Gastrointestinal Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Gastrointestinal Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Gastrointestinal Therapeutics Market Share by Players in 2019
Figure 13. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2019
Figure 15. North America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…- 胃腸装置の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Devices Market The global Gastrointestinal Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Devices Scope and Market Size Gastrointestinal D…
- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 短腸症候群の世界市場（～2026年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…
- 消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …